|
|
|
| Comparison on the curative effect of the focus excision combined with uterine artery blockade or uterine artery embolization for treating patients with type III cesarean scar pregnancy |
| Wenchang City Qingling Maternal and Child Health Care Hospital，Wenchang, Hainan Province, 571300 |
|
|
|
|
Abstract To explore the curative effect of the focus excision(FER) combined with uterine artery blockade(UAB) and uterine artery embolization(UAE) for treating patients with type III cesarean scar pregnancy(CSP). Methods: A retrospective analysis was performed on 92 patients with type III CSP between January 2019 and January 2021. According to different surgical methods, these patients were divided into group A(39 cases with UAB combined with FER) and group B(53 cases with UAE combined with FER). The operation time, the intraoperative blood loss, the postoperative intrauterine drainage volume, the hospitalization time, the hospitalization cost, the stopping time of postoperative vaginal bleeding, the recovery time of temperature to normal, the difference value of β human chorionic gonadotropin(β-HCG), in the 1st day after surgery, and the menstruation recovery time of the patients were compared between the two groups. The occurrence of the postoperative complications of the patients in both groups was recorded. Results: The operative time(33.0±2.5 min), the blood loss(82.2±13.6 ml), the postoperative uterine drainage volume(19.9±3.1 ml), the time of hospital stay(6.0±1.6 d), and the hospitalization cost(10.9 ±4.7 thousand yuan) of the patients in A group were all significantly lower than those(39.8±2.8 min, 119.5±20.2 ml, 25.0±5.0 ml, 8.7±2.1 d, and 14.4±5.2 thousand yuan) of the patients in group B(P＜0.05). There were no significant differences in the stopping time of postoperative vaginal bleeding, the recovery time of temperature to normal, the difference value ofβ-HCG in the 1st day after surgery, and the menstruation recovery time of the patients between the two groups(P>0.05). There was no significant difference in the incidence of postoperative complications(18.0% vs.22.6%) of the patients between the two groups(P>0.05). Conclusion: Compared with those of UAE combined with FER for treating the patients with type III CSP, UAB combined with FER for treating the patients can reduce their intraoperative blood loss, their postoperative intrauterine drainage volume, their hospitalization stay time, and their hospitalization cost, with few complications and significant curative effect.
|
|
|
|
|
|
|
|
|
